Literature DB >> 19752282

Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.

Ji-Yoeun Suh1, Jun Seong Son, Doo Ryeon Chung, Kyong Ran Peck, Kwan Soo Ko, Jae-Hoon Song.   

Abstract

In vitro activities of colistin and other drugs were tested against 221 Klebsiella pneumoniae isolates that were collected between 2006 and 2007 in nine tertiary care South Korean hospitals from patients with bacteremia. The clonality of colistin-resistant K. pneumoniae (CRKP) isolates was assessed by multilocus sequence typing (MLST). We found that 15 isolates (6.8%) were resistant to colistin. MLST showed that CRKP isolates were nonclonal, with colistin resistance in K. pneumoniae occurring independently and not by clonal spreading.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19752282      PMCID： PMC2798536          DOI： 10.1128/AAC.00762-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors:  Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

2.  Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.

Authors:  Joshua S Hawley; Clinton K Murray; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

3.  The in-vitro activity of colistin in gram-negative bacteria.

Authors:  T Y Tan; S Y Ng
Journal:  Singapore Med J       Date:  2006-07       Impact factor: 1.858

4.  Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Authors:  Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.

Authors:  Anastasia Antoniadou; Flora Kontopidou; Garifalia Poulakou; Evangelos Koratzanis; Irene Galani; Evangelos Papadomichelakis; Petros Kopterides; Maria Souli; Apostolos Armaganidis; Helen Giamarellou
Journal:  J Antimicrob Chemother       Date:  2007-02-16       Impact factor: 5.790

6.  Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors:  Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.

Authors:  Simona Bratu; Pooja Tolaney; Usha Karumudi; John Quale; Mohamad Mooty; Satyen Nichani; David Landman
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

8.  High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

Authors:  Kwan Soo Ko; Ji Yoeun Suh; Ki Tae Kwon; Sook-In Jung; Kyong-Hwa Park; Cheol In Kang; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Antimicrob Chemother       Date:  2007-08-29       Impact factor: 5.790

9.  Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.

Authors:  Jian Li; Roger L Nation; Roxanne J Owen; Stephanie Wong; Denis Spelman; Clare Franklin
Journal:  Clin Infect Dis       Date:  2007-07-17       Impact factor: 9.079

10.  Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

Authors:  A C Gales; R N Jones; H S Sader
Journal:  Clin Microbiol Infect       Date:  2006-04       Impact factor: 8.067
View more
  25 in total

1.  Colistin resistance in Enterobacter spp. isolates in Korea.

Authors:  Yoon-Kyoung Hong; Ji-Young Lee; Kwan Soo Ko
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

2.  Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.

Authors:  Tatiana Bogdanovich; Jennifer M Adams-Haduch; Guo-Bao Tian; Minh Hong Nguyen; Eun Jeong Kwak; Carlene A Muto; Yohei Doi
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

Review 3.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin-lipopolysaccharide binding interactions.

Authors:  Rachel L Soon; Tony Velkov; Francis Chiu; Philip E Thompson; Rashmi Kancharla; Kade Roberts; Ian Larson; Roger L Nation; Jian Li
Journal:  Anal Biochem       Date:  2010-11-02       Impact factor: 3.365

5.  Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999-2009.

Authors:  Yong-Hak Kim
Journal:  J Microbiol       Date:  2016-01-05       Impact factor: 3.422

6.  Molecular Epidemiology of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae in Serbia from 2013 to 2016.

Authors:  Katarina Novović; Anika Trudić; Snežana Brkić; Zorica Vasiljević; Milan Kojić; Deana Medić; Ivana Ćirković; Branko Jovčić
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 7.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 8.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.

Authors:  Myung-Jin Choi; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

10.  Differential expression of two-component systems, pmrAB and phoPQ, with different growth phases of Klebsiella pneumoniae in the presence or absence of colistin.

Authors:  So Yeon Kim; Hyeon Jin Choi; Kwan Soo Ko
Journal:  Curr Microbiol       Date:  2014-03-01       Impact factor: 2.188
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.